Return to our Home Page
Novagen Home Page

Tech Resources
TB283 His•Tag® MAb Protocol
MSDS - English
Other Languages
Selected Citations
Store
2 to 8°C2 to 8°C
Ship
Shipped at Ambient Temperature or with Blue IceAmbient or blue ice
Note: Store and Ship conditions may differ.
See Key
  5% Alkali-soluble Casein
Cat. No. 70955  
All Categories » Novagen » Protein Expression, Purification, and Detection » Protein Detection » Chemiluminescence and Blocking Supplies
Product Description

Alkali-Soluble Casein is a superior blocking reagent for Western blot applications. This preparation minimizes non-specific background relative to other blocking reagents, such as BSA, gelatin, or non-fat milk. Alkali-Soluble Casein is effective in colorimetric and chemiluminescent detection protocols. Note that due to its high coating properties, detection sensitivity for some antibodies may be lower than with other blocking reagents under the same conditions (although the background is also reduced); the concentration can be optimized for maximal signal:noise ratios. Supplied as a 5% w/v solution; recommended working concentration range is 0.25–1%.  

Need additional information about this product? Email our Technical Service department at: novatech@novagen.com

 Related information for this product is available:

EMD Chemicals Inc. list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.

Cat. No.
Size
In Stock
Select Country Above
For Pricing Information
70955-3225 mlYN/A

Material Safety Data Sheets:
70955: 5% Alkali-soluble Casein - English
Bulgarian
Danish
Dutch
Finnish
French
German
Greek
Hungarian
Italian
Korean
Norwegian
Polish
Portuguese
Spanish
Swedish

Related Categories:
All Categories » Calbiochem » Antibodies » Support Products » Immunodetection Reagents
All Categories » Novagen » Protein Expression, Purification, and Detection » Protein Detection » Chemiluminescence and Blocking Supplies

Selected Citations:
  1. Aileen Aherne, et al. (2004) On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa. Human Molecular Genetics 13, 641-650.